Funder: American Federation for Aging Research
Due Dates (Anticipated): February 2027 (LOI) | July 2027 (Full application)
Funding Amounts: $555,000 over three years, paid in annual installments of $185,000
Summary: Supports pioneering discoveries in the biology of normal human aging with potential to improve human healthspan.
Key Information: Assistant Professors must hold established R01 or equivalent funding to qualify.
Description
The Glenn Foundation for Medical Research, in collaboration with the American Federation for Aging Research (AFAR), supports research into the biological mechanisms governing normal human aging and its associated physiological decline. Proposals may come from any branch of biology. The program specifically welcomes investigators new to aging research whose expertise could advance understanding of normal aging and age-associated health decline.
The award supports new projects in established laboratories rather than incremental research. Priorities include discoveries applicable to human aging and healthspan, and new approaches to clinically relevant strategies, treatments, or therapeutics. Projects characterizing aging as a disease or focusing on specific diseases are discouraged unless they directly connect to aging biology or offer translational discoveries relevant to improving human healthspan.
